You are here: Industry Insights > BioNTech

News List

COVID-19 vaccine over 90 per cent effective: Pfizer expresspharma
November 10, 2020
Pfizer and BioNTech said they have so far found no serious safety concerns and expect to seek US authorisation this month for emergency use of the vaccine.
Pfizer, BioNTech COVID-19 Vax Candidate Successful in Phase III Interim Analysis contractpharma
November 10, 2020
mRNA-based vaccine candidate BNT162b2 found to be more than 90% effective in preventing COVID-19.
Pfizer and BioNTech enter Covid-19 vaccine deal with New Zealand pharmaceutical-technology
October 14, 2020
Pfizer and BioNTech have entered an agreement with the New Zealand Government to supply 1.5 million doses of their potential Covid-19 vaccine.
Rentschler Biopharma Enters COVID-19 Vax Agreement with BioNTech contractpharma
October 10, 2020
Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has entered an agreement to serve as CDMO partner for BioNTech.
BioNTech to Acquire GMP Manufacturing Site americanpharmaceuticalreview
September 27, 2020
BioNTech announced the signing of a share purchase agreement with Novartis AG, Basel / Switzerland to acquire their GMP certified manufacturing facility in Marburg, Germany.
Pfizer and BioNTech submit proposal to US FDA to expand COVID-19 vaccine trial expresspharma
September 24, 2020
The companies expect that a conclusive readout on efficacy is likely by the end of October.
Pfizer, BioNTech could supply EU with 300m doses of SARS-CoV-2 vaccine pharmatimes
September 24, 2020
Pfizer and BioNTech have concluded exploratory talks with the European Commission for a proposed supply of 200 million doses of their investigational BNT162 mRNA-based vaccine candidate against SARS-CoV-2 to EU nations ...
Pfizer, BioNTech Inch Closer to COVID-19 Vax Deal with EU contractpharma
September 24, 2020
Could supply the EU with 200 million doses of mRNA-based vaccine candidate against SARS-CoV-2.
Pfizer and BioNTech to potentially supply EU with 200 mn doses of COVID-19 vaccine candidate expresspharma
September 23, 2020
The proposed agreement also has an option to purchase additional 100 million doses, with deliveries starting by the end of 2020, subject to regulatory approval.
BioNTech to Receive Funding to Support COVID-19 Vaccine Program americanpharmaceuticalreview
September 22, 2020
BioNTech announced it will receive a grant of up to 375 million Euro from an initiative by the German Federal Ministry of Education and Research (BMBF) to support the accelerated development of SARS-CoV-2 vaccines.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page